Lifecycle Management
A Hybrid Archetyping Approach for Late Lifecycle Planning
Market archetypes provide a structured way to simplify complexity without losing strategic nuance, however, for late lifecycle planning, not all pharma archetyping approaches are equally effective.
Lifecycle Management
Loss of Exclusivity: Key Factors Shaping Local Market Dynamics
Success post-loss of exclusivity is heavily determined by your local strategies and planning. We take a look at the key factors shaping local market dynamics and why they matter to your strategy.
Lifecycle Management
Going Beyond Indication Expansion: A Framework for Rethinking Lifecycle Management
Introducing a lifecycle management framework to help pharmaceutical teams go beyond indication expansion by considering the breadth, depth, and sustainability of an asset.
Lifecycle Management
Early Lifecycle Management: Your Compass for Unlocking Asset Value
Developing a new pharmaceutical asset is not unlike the voyage of cargo ship: success depends on having a compass to guide you. In pharma, that compass is early lifecycle management planning.
Lifecycle Management
Six Strategy Decision Points for Effective Lifecycle Management
Maximize pharma asset value with our infographic: Six Strategic Decision Points for balanced Lifecycle Management success.
Lifecycle Management
5 Best Practices In Late Lifecycle Management
Navigate brand challenges with tailored Lifecycle Management. Explore 5 key practices for success as your portfolio evolves.
Lifecycle Management
PM360 – When it Comes to Lifecycle Management, Integrate, Don’t Ignore Uncertainty
Discover PM360 Resource on Integration for Lifecycle Management Success. Neal Hansen from Align Strategy explains how effective risk integration enhances planning.
Lifecycle Management
How to Analyse Unmet Needs to Drive Opportunity
Capture and build on unmet needs during indication prioritisation. Avoid oversimplification to seize true opportunities for developmental assets.
Lifecycle Management
How to Define Your Addressable Patient Population
Amid disease population complexities, pharma must avoid overlooking valuable opportunities for innovative patient solutions.
Webinar: Unlocking Durable Asset Value
What does a strong lifecycle management plan empower you to do with an early-stage asset? And what’s at stake if you don’t have one in place? In this on-demand webinar, Dr. Neal Hansen shares sharp insights on how early lifecycle management can dramatically impact a product’s long-term value – and what effective planning looks like in practice.
We’ve built this to be your source for insightful LCM thought leadership from leading advisors in this space.
Here, you’ll find content on the importance of putting strategy at the heart of LCM, guidance on planning ahead for multi-indication assets, plus practical advice on themes like establishing common goals to drive cross-functional alignment.
Maximize your chance for success across the lifecycle of your assets with expert advice from our consultants. Read more now.
